United States Endothelin Receptor Antagonist Market Research Report Forecast 2017 to 2022

December 2017 | 115 pages | ID: U819A73E817EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The United States Endothelin Receptor Antagonist Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Endothelin Receptor Antagonist industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Endothelin Receptor Antagonist market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:
Actelion Pharmaceuticals Ltd.
United Therapeutics Corporation
Gilead sciences
Bayer AG
SteadyMed Ltd.
GlaxoSmithKline plc
Pfizer Inc.
Reata Pharmaceuticals Inc.
Arena Pharmaceuticals Inc.

United States Endothelin Receptor Antagonist Market: Product Segment Analysis
Type 1
Type 2
Type 3

United States Endothelin Receptor Antagonist Market: Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 ENDOTHELIN RECEPTOR ANTAGONIST MARKET OVERVIEW

1.1 Product Overview and Scope of Endothelin Receptor Antagonist
1.2 Endothelin Receptor Antagonist Market Segmentation by Type
  1.2.1 United States Production Market Share of Endothelin Receptor Antagonist by Type in 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Endothelin Receptor Antagonist Market Segmentation by Application
  1.3.1 Endothelin Receptor Antagonist Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Endothelin Receptor Antagonist (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON ENDOTHELIN RECEPTOR ANTAGONIST INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES ENDOTHELIN RECEPTOR ANTAGONIST MARKET COMPETITION BY MANUFACTURERS

3.1 United States Endothelin Receptor Antagonist Production and Share by Manufacturers (2015 and 2016)
3.2 United States Endothelin Receptor Antagonist Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Endothelin Receptor Antagonist Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Endothelin Receptor Antagonist Manufacturing Base Distribution, Production Area and Product Type
3.5 Endothelin Receptor Antagonist Market Competitive Situation and Trends
  3.5.1 Endothelin Receptor Antagonist Market Concentration Rate
  3.5.2 Endothelin Receptor Antagonist Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES ENDOTHELIN RECEPTOR ANTAGONIST PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Endothelin Receptor Antagonist Production and Market Share by Type (2012-2017)
4.2 United States Endothelin Receptor Antagonist Revenue and Market Share by Type (2012-2017)
4.3 United States Endothelin Receptor Antagonist Price by Type (2012-2017)
4.4 United States Endothelin Receptor Antagonist Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES ENDOTHELIN RECEPTOR ANTAGONIST MARKET ANALYSIS BY APPLICATION

5.1 United States Endothelin Receptor Antagonist Consumption and Market Share by Application (2012-2017)
5.2 United States Endothelin Receptor Antagonist Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES ENDOTHELIN RECEPTOR ANTAGONIST MANUFACTURERS ANALYSIS

6.1 Actelion Pharmaceuticals Ltd.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 United Therapeutics Corporation
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Gilead sciences
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 Bayer AG
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 SteadyMed Ltd.
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 GlaxoSmithKline plc
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Pfizer Inc.
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 Reata Pharmaceuticals Inc.
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 Arena Pharmaceuticals Inc.
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 ENDOTHELIN RECEPTOR ANTAGONIST MANUFACTURING COST ANALYSIS

7.1 Endothelin Receptor Antagonist Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Endothelin Receptor Antagonist

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Endothelin Receptor Antagonist Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Endothelin Receptor Antagonist Major Manufacturers in 2016
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES ENDOTHELIN RECEPTOR ANTAGONIST MARKET FORECAST (2017-2022)

11.1 United States Endothelin Receptor Antagonist Production, Revenue Forecast (2017-2022)
11.2 United States Endothelin Receptor Antagonist Production, Consumption Forecast by Regions (2017-2022)
11.3 United States Endothelin Receptor Antagonist Production Forecast by Type (2017-2022)
11.4 United States Endothelin Receptor Antagonist Consumption Forecast by Application (2017-2022)
11.5 Endothelin Receptor Antagonist Price Forecast (2017-2022)

CHAPTER 12 APPENDIX

List Of Tables

LIST OF TABLES

Figure Picture of Endothelin Receptor Antagonist
Table Classification of Endothelin Receptor Antagonist
Figure United States Sales Market Share of Endothelin Receptor Antagonist by Type in 2016
Table Application of Endothelin Receptor Antagonist
Figure United States Sales Market Share of Endothelin Receptor Antagonist by Application in 2016
Figure United States Endothelin Receptor Antagonist Sales and Growth Rate (2011-2021)
Figure United States Endothelin Receptor Antagonist Revenue and Growth Rate (2011-2021)
Table United States Endothelin Receptor Antagonist Sales of Key Manufacturers (2015 and 2016)
Table United States Endothelin Receptor Antagonist Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Endothelin Receptor Antagonist Sales Share by Manufacturers
Figure 2016 Endothelin Receptor Antagonist Sales Share by Manufacturers
Table United States Endothelin Receptor Antagonist Revenue by Manufacturers (2015 and 2016)
Table United States Endothelin Receptor Antagonist Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Endothelin Receptor Antagonist Revenue Share by Manufacturers
Table 2016 United States Endothelin Receptor Antagonist Revenue Share by Manufacturers
Table United States Market Endothelin Receptor Antagonist Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Endothelin Receptor Antagonist Average Price of Key Manufacturers in 2015
Figure Endothelin Receptor Antagonist Market Share of Top 3 Manufacturers
Figure Endothelin Receptor Antagonist Market Share of Top 5 Manufacturers
Table United States Endothelin Receptor Antagonist Sales by Type (2012-2017)
Table United States Endothelin Receptor Antagonist Sales Share by Type (2012-2017)
Figure United States Endothelin Receptor Antagonist Sales Market Share by Type in 2015
Table United States Endothelin Receptor Antagonist Revenue and Market Share by Type (2012-2017)
Table United States Endothelin Receptor Antagonist Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Endothelin Receptor Antagonist by Type (2012-2017)
Table United States Endothelin Receptor Antagonist Price by Type (2012-2017)
Figure United States Endothelin Receptor Antagonist Sales Growth Rate by Type (2012-2017)
Table United States Endothelin Receptor Antagonist Sales by Application (2012-2017)
Table United States Endothelin Receptor Antagonist Sales Market Share by Application (2012-2017)
Figure United States Endothelin Receptor Antagonist Sales Market Share by Application in 2016
Table United States Endothelin Receptor Antagonist Sales Growth Rate by Application (2012-2017)
Figure United States Endothelin Receptor Antagonist Sales Growth Rate by Application (2012-2017)
Table Actelion Pharmaceuticals Ltd. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Actelion Pharmaceuticals Ltd. Endothelin Receptor Antagonist Production, Revenue, Price and Gross Margin (2012-2017)
Table Actelion Pharmaceuticals Ltd. Endothelin Receptor Antagonist Market Share (2012-2017)
Table United Therapeutics Corporation Basic Information, Manufacturing Base, Production Area and Its Competitors
Table United Therapeutics Corporation Endothelin Receptor Antagonist Production, Revenue, Price and Gross Margin (2012-2017)
Table United Therapeutics Corporation Endothelin Receptor Antagonist Market Share (2012-2017)
Table Gilead sciences Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Gilead sciences Endothelin Receptor Antagonist Production, Revenue, Price and Gross Margin (2012-2017)
Table Gilead sciences Endothelin Receptor Antagonist Market Share (2012-2017)
Table Bayer AG Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bayer AG Endothelin Receptor Antagonist Production, Revenue, Price and Gross Margin (2012-2017)
Table Bayer AG Endothelin Receptor Antagonist Market Share (2012-2017)
Table SteadyMed Ltd. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table SteadyMed Ltd. Endothelin Receptor Antagonist Production, Revenue, Price and Gross Margin (2012-2017)
Table SteadyMed Ltd. Endothelin Receptor Antagonist Market Share (2012-2017)
Table GlaxoSmithKline plc Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline plc Endothelin Receptor Antagonist Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline plc Endothelin Receptor Antagonist Market Share (2012-2017)
Table Pfizer Inc. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Inc. Endothelin Receptor Antagonist Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Inc. Endothelin Receptor Antagonist Market Share (2012-2017)
Table Reata Pharmaceuticals Inc. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Reata Pharmaceuticals Inc. Endothelin Receptor Antagonist Production, Revenue, Price and Gross Margin (2012-2017)
Table Reata Pharmaceuticals Inc. Endothelin Receptor Antagonist Market Share (2012-2017)
Table Arena Pharmaceuticals Inc. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Arena Pharmaceuticals Inc. Endothelin Receptor Antagonist Production, Revenue, Price and Gross Margin (2012-2017)
Table Arena Pharmaceuticals Inc. Endothelin Receptor Antagonist Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Endothelin Receptor Antagonist
Figure Manufacturing Process Analysis of Endothelin Receptor Antagonist
Figure Endothelin Receptor Antagonist Industrial Chain Analysis
Table Raw Materials Sources of Endothelin Receptor Antagonist Major Manufacturers in 2016
Table Major Buyers of Endothelin Receptor Antagonist
Table Distributors/Traders List
Figure United States Endothelin Receptor Antagonist Production and Growth Rate Forecast (2017-2022)
Figure United States Endothelin Receptor Antagonist Revenue and Growth Rate Forecast (2017-2022)
Table United States Endothelin Receptor Antagonist Production Forecast by Type (2017-2022)
Table United States Endothelin Receptor Antagonist Consumption Forecast by Application (2017-2022)

COMPANIES MENTIONED

Actelion Pharmaceuticals Ltd.
United Therapeutics Corporation
Gilead sciences
Bayer AG
SteadyMed Ltd.
GlaxoSmithKline plc
Pfizer Inc.
Reata Pharmaceuticals Inc.
Arena Pharmaceuticals Inc.
Merck & Co. Inc